Delivery Order SPE2DB22D3501-SPE2DB25FWX80
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This delivery order, valued at $132,136, was awarded on July 21, 2025, to AmerisourceBergen Drug Corp for supply of Ipol vial 5ML pharmaceutical products. The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The Defense Logistics Agency (DLA), which manages the federal medical supply chain, funded this award under firm fixed-price...
- The Defense Logistics Agency Troop Support Medical awarded a $273,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IPOL vials. The order is for 4561322355 5mL vials of IPOL to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 26, 2023. Amerisourcebergen will provide the vials in support of the Defense Logistics Agency's medical supply chain initiatives. No subcontractors or set aside designations were identified. The delivery order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-nine thousand, six hundred fifty-eight dollars and eighty-three cents ($39,658.83) to Amerisourcebergen Drug Corporation for 4561651255 IPOL vials (5ml each). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 31, 2023 through August 1, 2023. No set aside designation or subcontractors were identified. The Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,900.02 firm fixed-price delivery order is for the provision of 10-dose vials of poliovirus vaccine. The contract has an ultimate completion date of April 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Department of Defense awarded a $59,335.20 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a completion date of October 2, 2023, is for the delivery of 4562356439 IPOL VIAL 5ML medical supplies. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWX80Delivery Order
The Defense Logistics Agency awarded a $2,307.21 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This firm fixed-price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric immunization pharmaceutical requirement within the federal medical supply chain. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for military and federal healthcare systems, supplying an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC vehicle enables the contractor to provide comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible delivery order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/19/25 |